Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ANGPTL4 anticorps

Cité dans 1 publication. Cet anticorps anti-ANGPTL4 Polyclonal Lapin (ABIN1169313) détecte spécifiquement ANGPTL4 dans WB et ELISA. L’anticorps est réactif avec des échantillons de Humain.
N° du produit ABIN1169313
275,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 2 à 5 jours ouvrables

Aperçu rapide pour ANGPTL4 anticorps (ABIN1169313)

Antigène

Voir toutes ANGPTL4 Anticorps
ANGPTL4 (Angiopoietin-Like 4 (ANGPTL4))

Reactivité

  • 103
  • 37
  • 29
  • 5
  • 4
  • 1
Humain

Hôte

  • 110
  • 20
  • 1
  • 1
Lapin

Clonalité

  • 113
  • 19
Polyclonal

Conjugué

  • 69
  • 16
  • 9
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ANGPTL4 est non-conjugé

Application

  • 76
  • 44
  • 39
  • 38
  • 10
  • 8
  • 5
  • 4
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Fonction

    anti-ANGPTL4 (human), pAb

    Specificité

    Recognizes human ANGPTL4. Detects a band of ~35 kDa and 62 kDa by Western blot.

    Attributs du produit

    Polyclonal Antibody. Recognizes human ANGPTL4. Detects a band of ~35 kDa and 62 kDa by Western blot. Source: Rabbit. Applications: ELISA, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. ANGPTL4 mainly expressed in endothelial cells (hypoxia-induced). Regulates angiogenesis and modulates tumorgenesis and directly regulates lipid, glucose, and energy metabolism. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 is a protein consisting of an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain (FLD). Both domains have distinct biological functions. The coiled-coil domain is responsible for the inhibitory effects on lipoprotein lipase (LPL) converting the active form of LPL into an inactive form, and the FLD domain mediates its antiangiogenic functions. The coiled coil and the FLD domains are separated by a short linker that can be cleaved after secretion. ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment. ANGPTL4 protein is then proteolytically cleaved by proprotein convertases (PCs), including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7.

    Stérilité

    0.2 μm filtered

    Immunogène

    Recombinant human ANGPTL4.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    +4°C

    -20°C

    Stable for at least 6 months after receipt when stored at -20°C.

    Date de péremption

    6 months
  • Broxmeyer, Srour, Cooper, Wallace, Hangoc, Youn: "Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors." dans: Blood cells, molecules & diseases, Vol. 48, Issue 1, pp. 25-9, (2012) (PubMed).

  • Antigène

    ANGPTL4 (Angiopoietin-Like 4 (ANGPTL4))

    Autre désignation

    ANGPTL4

    Sujet

    Alternate Names/Synonyms: Angiopoietin-like Protein 4, FIAF, Fasting-induced Adipose Factor, HFARP, Hepatic Fibrinogen/Angiopoietin-related Protein

    Product Description: ANGPTL4 mainly expressed in endothelial cells (hypoxia-induced). Regulates angiogenesis and modulates tumorgenesis and directly regulates lipid, glucose, and energy metabolism. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 is a protein consisting of an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain (FLD). Both domains have distinct biological functions. The coiled-coil domain is responsible for the inhibitory effects on lipoprotein lipase (LPL) converting the active form of LPL into an inactive form, and the FLD domain mediates its antiangiogenic functions. The coiled coil and the FLD domains are separated by a short linker that can be cleaved after secretion. ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment. ANGPTL4 protein is then proteolytically cleaved by proprotein convertases (PCs), including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7.

    UniProt

    Q9BY76

    Pathways

    Regulation of Lipid Metabolism by PPARalpha
Vous êtes ici:
Chat with us!